The invention provides an improved method of treating a human suffering from
one or more conditions included within the Coronary Heart Disease Risk Factor (CHDRF)
syndrome. The method includes administering, by a pharmaceutically effective mode,
a drug composition having an opioidergic agent including an opiate antagonist,
opiate having -agonist activity or combination thereof, and an insulin secretagogue.
